Harmful variants in human BTK cause X-linked agammaglobulinemia (XLA), a primary immunodeficiency (Mohamed et al., 2009), in mouse X-linked immunodeficiency (Khan et al., 1995). Here, BTK is linked to X-linked agammaglobulinemia.